The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Sanofi
Consulting or Advisory Role - Lilly; Sanofi
Travel, Accommodations, Expenses - Amgen; Merck; Roche; Sanofi
Randomized phase 2 study of paclitaxel (PTX), trastuzumab (T) with or without MM-111 in HER2 expressing gastroesophageal cancers (GEC).
 
Crystal Shereen Denlinger
Consulting or Advisory Role - Lilly; Merrimack
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); Genentech/Roche (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst); Pfizer (Inst)
 
Maria Alsina Maqueda
No Relationships to Disclose
 
David J. Watkins
No Relationships to Disclose
 
Sun Jin Sym
No Relationships to Disclose
 
Johanna C. Bendell
No Relationships to Disclose
 
Se Hoon Park
No Relationships to Disclose
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris
 
Art J. Kudla
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
Patents, Royalties, Other Intellectual Property - Merrimack
 
Charlotte Fenton McDonagh
Employment - Merrimack
Stock and Other Ownership Interests - Alexion Pharmaceuticals; Alexion Pharmaceuticals (I); Amgen; Amgen (I); Biogen; Biogen (I); Merrimack; Merrimack (I); Seagen; Seagen (I)
Patents, Royalties, Other Intellectual Property - Merrimack; Seagen
 
Akos Gabor Czibere
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
Patents, Royalties, Other Intellectual Property - Merrimack
 
Benoist Chibaudel
No Relationships to Disclose
 
Michael F. Press
Honoraria - Amgen; Biocartis; Cepheid; Dako; GlaxoSmithKline; Halozyme; NanoString Technologies; OncoMed; Puma Biotechnology
Consulting or Advisory Role - Amgen; Biocartis; Cepheid; Dako; GlaxoSmithKline; Halozyme; NanoString Technologies; OncoMed; Puma Biotechnology
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Dako; Dendreon
 
Harry H. Yoon
Honoraria - Five Prime Therapeutics; Lilly
Consulting or Advisory Role - Five Prime Therapeutics; Lilly
Research Funding - Lilly/ImClone; Roche/Genentech
Travel, Accommodations, Expenses - Lilly
 
J. Randolph Hecht
No Relationships to Disclose
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Yung-Jue Bang
Research Funding - Merrimack (Inst)